Viral membranes: An emerging antiviral target for enveloped viruses?

Jae Min Song, Baik Lin Seong

Research output: Contribution to journalComment/debate

6 Citations (Scopus)

Abstract

The emergence and re-emergence of viruses and the widespread antiviral resistance calls for the development of a broad-spectrum strategy for viral infection. The article under review describes an approach to achieve this goal by developing an antiviral rhodanine derivative effective against enveloped viruses targeting the viral lipid membrane. By intercalating into the viral membrane, the compound irreversibly inactivates the virions with virucidal effects. Potential toxic effects on hosts could be minimized by continuous regeneration of cellular membranes. The present strategy exploits the therapeutic window that exists between static viral membranes and biogenic cellular membranes and provides a useful guideline for future research endeavors towards broad-spectrum antiviral approaches for enveloped viruses. Developing a formulation that ensures efficient delivery and pharmacokinetic properties while minimizing systemic toxicity on cell membranes remains a challenge. The advantages and disadvantages of a viral membrane-targeting approach for the control of emerging and re-emerging viruses will be discussed.

Original languageEnglish
Pages (from-to)635-638
Number of pages4
JournalExpert Review of Anti-Infective Therapy
Volume8
Issue number6
DOIs
Publication statusPublished - 2010 Jun 1

Fingerprint

Antiviral Agents
Viruses
Membranes
Rhodanine
Poisons
Virus Diseases
Membrane Lipids
Virion
Regeneration
Pharmacokinetics
Cell Membrane
Guidelines
Therapeutics

All Science Journal Classification (ASJC) codes

  • Microbiology
  • Microbiology (medical)
  • Infectious Diseases
  • Virology

Cite this

@article{461a12e413d341fb89fb93031f613a2a,
title = "Viral membranes: An emerging antiviral target for enveloped viruses?",
abstract = "The emergence and re-emergence of viruses and the widespread antiviral resistance calls for the development of a broad-spectrum strategy for viral infection. The article under review describes an approach to achieve this goal by developing an antiviral rhodanine derivative effective against enveloped viruses targeting the viral lipid membrane. By intercalating into the viral membrane, the compound irreversibly inactivates the virions with virucidal effects. Potential toxic effects on hosts could be minimized by continuous regeneration of cellular membranes. The present strategy exploits the therapeutic window that exists between static viral membranes and biogenic cellular membranes and provides a useful guideline for future research endeavors towards broad-spectrum antiviral approaches for enveloped viruses. Developing a formulation that ensures efficient delivery and pharmacokinetic properties while minimizing systemic toxicity on cell membranes remains a challenge. The advantages and disadvantages of a viral membrane-targeting approach for the control of emerging and re-emerging viruses will be discussed.",
author = "Song, {Jae Min} and Seong, {Baik Lin}",
year = "2010",
month = "6",
day = "1",
doi = "10.1586/eri.10.51",
language = "English",
volume = "8",
pages = "635--638",
journal = "Expert Review of Anti-Infective Therapy",
issn = "1478-7210",
publisher = "Expert Reviews Ltd.",
number = "6",

}

Viral membranes : An emerging antiviral target for enveloped viruses? / Song, Jae Min; Seong, Baik Lin.

In: Expert Review of Anti-Infective Therapy, Vol. 8, No. 6, 01.06.2010, p. 635-638.

Research output: Contribution to journalComment/debate

TY - JOUR

T1 - Viral membranes

T2 - An emerging antiviral target for enveloped viruses?

AU - Song, Jae Min

AU - Seong, Baik Lin

PY - 2010/6/1

Y1 - 2010/6/1

N2 - The emergence and re-emergence of viruses and the widespread antiviral resistance calls for the development of a broad-spectrum strategy for viral infection. The article under review describes an approach to achieve this goal by developing an antiviral rhodanine derivative effective against enveloped viruses targeting the viral lipid membrane. By intercalating into the viral membrane, the compound irreversibly inactivates the virions with virucidal effects. Potential toxic effects on hosts could be minimized by continuous regeneration of cellular membranes. The present strategy exploits the therapeutic window that exists between static viral membranes and biogenic cellular membranes and provides a useful guideline for future research endeavors towards broad-spectrum antiviral approaches for enveloped viruses. Developing a formulation that ensures efficient delivery and pharmacokinetic properties while minimizing systemic toxicity on cell membranes remains a challenge. The advantages and disadvantages of a viral membrane-targeting approach for the control of emerging and re-emerging viruses will be discussed.

AB - The emergence and re-emergence of viruses and the widespread antiviral resistance calls for the development of a broad-spectrum strategy for viral infection. The article under review describes an approach to achieve this goal by developing an antiviral rhodanine derivative effective against enveloped viruses targeting the viral lipid membrane. By intercalating into the viral membrane, the compound irreversibly inactivates the virions with virucidal effects. Potential toxic effects on hosts could be minimized by continuous regeneration of cellular membranes. The present strategy exploits the therapeutic window that exists between static viral membranes and biogenic cellular membranes and provides a useful guideline for future research endeavors towards broad-spectrum antiviral approaches for enveloped viruses. Developing a formulation that ensures efficient delivery and pharmacokinetic properties while minimizing systemic toxicity on cell membranes remains a challenge. The advantages and disadvantages of a viral membrane-targeting approach for the control of emerging and re-emerging viruses will be discussed.

UR - http://www.scopus.com/inward/record.url?scp=77953262931&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953262931&partnerID=8YFLogxK

U2 - 10.1586/eri.10.51

DO - 10.1586/eri.10.51

M3 - Comment/debate

C2 - 20521891

AN - SCOPUS:77953262931

VL - 8

SP - 635

EP - 638

JO - Expert Review of Anti-Infective Therapy

JF - Expert Review of Anti-Infective Therapy

SN - 1478-7210

IS - 6

ER -